title: [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
authors.affiliation: Servicio de Anestesiología y Reanimación, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, España.
authors.forename: A
authors.initials: A
authors.lastname: Abad Gurumeta
authors.forename: R
authors.initials: R
authors.lastname: Gutiérrez García
mesh_terms: D000707:Anaphylaxis / Q000139:chemically induced / Q000188:drug therapy* / Q000453:epidemiology; D000732:Androstanols / Q000009:adverse effects* / Q000276:immunology / Q000493:pharmacokinetics; D002395:Catecholamines / Q000627:therapeutic use; D004341:Drug Evaluation; D004342:Drug Hypersensitivity / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D004351:Drug Resistance; D006801:Humans; D007073:Immunoglobulin E / Q000276:immunology; D019148:Neuromuscular Blockade / Q000009:adverse effects; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects* / Q000276:immunology / Q000493:pharmacokinetics; D012107:Research Design; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000493:pharmacokinetics / Q000627:therapeutic use*
chemical_list: D000732:Androstanols; D002395:Catecholamines; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D007073:Immunoglobulin E; D000077123:Rocuronium